EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, vol.67, no.12, pp.1223-1229, 2011 (SCI-Expanded)
To evaluate the impact of polymorphisms in the cytochrome P450 (CYP) 2C9, 2C19 and 2C8 genes on the risk of mild hypoglycaemic attacks in patients treated with sulphonylureas.